Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers

Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers
复制标题

DOI:
10.1160/th06-09-0523
复制
发表时间:
2007-03-01
影响因子:
6.7
通讯作者:
Francis, John L.
Francis, John L.
中科院分区:
医学2区
文献类型:
--
作者:
Langer, Florian;Chun, Felix Kyoung-Hwan;Francis, John L.

文献摘要

被引文献

相似文献

组织因子(TF)参与癌症的生长和转移,并且在大多数晚期恶性肿瘤(包括前列腺癌(PC))患者中发现止血异常。由于抗止血剂越来越多地筛选其延长肿瘤患者生存期的潜力,在选定的癌症亚型和临床阶段的止血标志物的详细表征是必要的。在这项研究中,我们测量了一个大型队列的局部PC患者的术前血浆TF抗原,并将其水平与凝血和血小板活化标志物、前列腺特异性抗原(PSA)和组织病理学结果相关联,以探讨其作为该肿瘤实体预后标志物的潜力。在140名患者中,19%和23%的血浆TF抗原水平分别< 40 pg/ml(低TF)和> 200 pg/ml(高TF),这远高于42名健康男性对照。患者还具有低级别的全身凝血激活,如升高的D-受体、F1+2和PAP血浆水平所证明的。此外,与sP-选择素和sCD 40 L抗原相似,血浆中血小板衍生微粒的流式细胞术分析显示,与低TF患者和对照组相比,高TF患者血小板衍生微粒的数量显著增加。尽管D-受体升高与较大和分化程度较低的肿瘤相关,但术前血浆TF抗原水平(中位数[IQR])在PC患者中(161 pg/ml [100-236])高于未复发PC患者(105 pg/ml [52-182]),如门诊随访期间血清PSA> 0.1 ng/ml所示。在局限性PC患者中,术前血浆TF抗原水平与体内血小板活化相关,并可能表明疾病复发的风险增加。
Tissue factor (TF) is involved in cancer growth and metastasis, and haemostatic abnormalities are found in most patients with advanced malignancies, including prostate cancer (PC). Because anti-haemostatic agents are increasingly screened for their potential to prolong survival in tumor patients, a detailed characterization of haemostatic markers in selected cancer subtypes and clinical stages is warranted. In this study, we measured Preoperative plasma TF antigen in a large cohort of patients with localized PC and correlated its levels with markers of coagulation and platelet activation, prostate-specific antigen (PSA), and histopathological findings to explore its potential as a prognostic marker in this tumor entity. Out of 140 patients, 19% and 23% had plasma TF antigen levels of < 40 pg/ml (low-TF) and > 200 pg/ml (high-TF), respectively, which was substantially higher than in 42 healthy male controls. Patients also had low-grade systemic coagulation activation as evidenced by elevated D-climer, F1+2, and PAP plasma levels. Furthermore, similar to sP-selectin and sCD40L antigen, flow cytometric analysis of platelet-derived microparticles in plasma revealed significantly increased numbers in high-TF as compared to low-TF patients and controls. Whereas elevated D-climer was associated with larger and less differentiated tumors, preoperative plasma TF antigen levels (median [IQR]) were higher in patients with (161 pg/ml [100-236]) than in those without recurrent PC (105 pg/ml [52-182]), as indicated by a serum PSA of > 0.1 ng/ml during ambulatory follow-up. In patients with localized PC, preoperative plasma TF antigen levels correlate with platelet activation in vivo and may indicate an increased risk for recurrent disease.